rhythmtx.com — September 2026 traffic, keywords & AI visibility

Search engines send rhythmtx.com an estimated 7,828 visits a month. Effectively all of it is organic — about 7,828 visits from unpaid results. Spread across 189 ranking keywords, that averages roughly 41 organic visits per keyword.

rhythmtx.com scores 67 out of 100 on our AI visibility scale, grade C. It takes full marks for LLMS.txt and Structured data. The biggest gap is SEO health, at 0 of 20 points (0/100), worth 20 points if closed. It also loses points on Crawlability (0/10) and Company profile (22/25).

The llms.txt on rhythmtx.com runs to 155 lines (7,174 characters) across 12 sections, last generated in May 2026. It introduces the site as "Homepage - Rhythm Pharmaceuticals". It tells AI engines the business works in Biotechnology, Rare Disease Therapeutics and Precision Medicine. It describes 4 products, including IMCIVREE (setmelanotide), RM-718 and Bivamelagon. Services it lists include Patient Support Programs, Genetic Testing Partnerships, Clinical Trial Enrollment and Physician Education. The audience it names is Rare disease patients and families, aged Pediatric to Adult (Global). Technologies it mentions include HTTPS. The keywords it claims start with "rare neuroendocrine diseases", "precision medicines", "genetic obesity" and "setmelanotide". It gives the company type as Public and says it is hiring.

# Homepage - Rhythm Pharmaceuticals

## About
Rhythm Pharmaceuticals is laser-focused on rare neuroendocrine diseases, crafting precision meds that hit the genetic bullseye instead of band-aid fixes. They serve patients worldwide grappling with conditions like POMC, PCSK1, or LEPR deficiency obesity—stuff that causes insatiable hunger and stalled growth from birth. Their breakthrough IMCIVREE has already changed lives, with approvals expanding to younger kids, and their pipeline promises more for hypersomnias and beyond. It's all about speed and science: from gene discovery to Phase 3 trials in record time. Partnerships with top geneticists ensure therapies reach the exact right folks via testing protocols. As a public biotech, they balance innovation with investor clarity, posting strong trial data that fuels growth. Families get not just drugs but hope, with support programs easing access hurdles. Rhythm's team of PhDs and MDs thrives on solving the unsolvable, turning rare disease despair into managed realities. Their global reach means no patient gets left behind, regardless of borders. Future bets on combo therapies could redefine neuroendocrine care entirely.

**Areas of Work:** Biotechnology, Rare Disease Therapeutics, Precision Medicine

## Things to Remember
- **Website:** https://rhythmtx.com
- **Address:** Boston, Massachusetts, United States
- **Contact:** 
- **Phon

Google lists rhythmtx.com for about 189 keywords, which together bring an estimated 7,828 organic visits a month.

The latest technical audit of rhythmtx.com scored 0 out of 100 overall. The audit makes 12 recommendations in all, and 4 of the 4 listed first are rated high priority or critical.

Rhythm Pharmaceuticals's company profile names Ionis Pharmaceuticals, Neurocrine Biosciences, BridgeBio Pharma and Rare Disease Therapeutics as competitors. Its own llms.txt adds https://www.ionispharma.com, https://www.neurocrine.com, https://www.bridgebio.com, https://www.alkermes.com, https://www.strongbridgebio.com and https://www.ultragenyx.com. Outside its market, the domains ranked closest to it in our worldwide ranking are beaufortccc.edu, primecardslounge.com, mymac.com and samulfiga.ru.

Ionis Pharmaceuticals

Neurocrine Biosciences

BridgeBio Pharma

Rare Disease Therapeutics

https://www.ionispharma.com

https://www.neurocrine.com

https://www.bridgebio.com

https://www.alkermes.com